[Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
作者信息
Warembourg H, Ketelers J Y, Ginestet A
出版信息
Lille Med. 1973 Dec;18(10 Suppl 5):suppl 5:1331-5.
PMID:4608970
Abstract
摘要
相似文献
1
[Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].[一种血脂正常剂的治疗试验：乙醇胺 N-氧代烟酸盐]
Lille Med. 1973 Dec;18(10 Suppl 5):suppl 5:1331-5.
2
[A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].一种新型降血脂药物的双盲交叉试验（作者译）
G Ital Cardiol. 1978;8(7):743-51.
3
[The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
Med Klin. 1974 Sep 6;69(36):1441-7.
4
5
[Clinical trials with Fonlipol. Apropos of 50 cases].[使用福脂醇的临床试验。关于50例病例]
Lille Med. 1974 Apr;19(4 Suppl 11):528-31.
6
[Clinical trial of tibric acid, a new hypolipidemic agent].[新型降血脂药物——替贝酸的临床试验]
Schweiz Med Wochenschr. 1974 Dec 21;104(51):1917-22.
7
[The management of hyperlipoproteinemia with Liproreduct].
Ther Ggw. 1974 May;113(5):813-24.
8
[Clinical experimentation of clofibride. Apropos of 40 cases].[氯贝丁酯的临床试验。附40例报告]
Lille Med. 1973 Dec;18(10 Suppl 5):suppl 5:1292-6.
9
A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.吉非贝齐治疗高脂血症的长期试验。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):49-52. doi: 10.1177/00359157760690S213.
10
Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.吉非贝齐和氯贝丁酯治疗高脂血症的比较试验。
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211.
Zotero 插件